- CPR/Resuscitation
-
Plasma biomarkers for brain injury in extracorporeal membrane oxygenation
-
Shrey Kapoor, Anna Kolchinski, Aaron M. Gusdon, Lavienraj Premraj, Sung-Min Cho
-
Acute Crit Care. 2023;38(4):389-398. Published online November 29, 2023
-
DOI: https://doi.org/10.4266/acc.2023.01368
-
-
 Abstract
 PDF
- Extracorporeal membrane oxygenation (ECMO) is a life-saving intervention for patients with refractory cardiorespiratory failure. Despite its benefits, ECMO carries a significant risk of neurological complications, including acute brain injury (ABI). Although standardized neuromonitoring and neurological care have been shown to improve early detection of ABI, the inability to perform neuroimaging in a timely manner is a major limitation in the accurate diagnosis of neurological complications. Therefore, blood-based biomarkers capable of detecting ongoing brain injury at the bedside are of great clinical significance. This review aims to provide a concise review of the current literature on plasma biomarkers for ABI in patients on ECMO support.
|
KSCCM
